| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 . 430 . 440 . 450 . 460 . 470 . 480 . 490 . 500 . 510 . 520 . 530 . 540 . 550 . 560 . 570 . 580 . 590 . 600 . 610 . 620 . 630 . 640 . 650 |
# |
Score |
Template |
Links and tools | %id | First |
MEDNNKTQAYDSSSIKILEGLEAVRKRPGMYIGSTGEEGLHHMIWEIIDNSIDEAMGGFASTVKLTLKDNFVTIVEDDGRGIPVDIHPKTNRSTVETVFTVLHAGGKFDNDSYKVSGGLHGVGASVVNALSSSFKVWVAREHQQYFLAFHNGGEVIGDLVNEGKCDKEHGTKVEFVPDFTVMEKSDYKQTVIASRLQQLAFLNKGIQIDFVDERRQNPQSFSWKYDGGLVQYIHHLNNEKEPLFEDIIFGEKTDTVKSVSRDESYTIKVEVAFQYNKTYNQSIFSFCNNINTTEGGTHVEGFRNALVKIINRFAVENKFLKETDEKITRDDICEGLTAIISIKHPNPQYEGQTKKKLGNTEVRPLVNSIVSEIFERFMLENPQEANAIIRKTLLAQEARRRSQEARELTRRKSPFDSGSLPGKLADCTTRDPSISELYIVEGDSAGGTAKTGRDRYFQAILPLRGKILNVEKSHFEQIFNNVEISALVMAVGCGIKPDFELEKLRYNKIIIMTDADVDGAHIRTLLLTFFFRFMYPLVEQGNIYIAQPPLYKVSYSNKDLYMQTDVQLEEWKQQHPNLKYNLQRYKGLGEMDAIQLWETTMDPKVRTLLKVTVEDASIADKAFSLLMGDEVPPRREFIEQNARNVKNIDI | Last |
1 | -57.900 | PF00204.25; A9KS52_LACP7/226-396; DNA gyrase B |
ali follow.. |
40 | 1 | ...................................................................................................................................................................................................................................GIKSFVSYINREASVIHEEPIYIE----------GKSGDIEVEVALQYTNSFSEQINAYCNRINVVDGGTLVTGFKTALTRVMNQYARELGVLKEKDENFDGKDIRNGLVTIISIKHPDPQFEGQTKTKLGNTDAKSAVEDVFSGEVTRFFDKNVEILKAILENSMRSYTARKASDKARSA.................................................................................................................................................................................................................................................. |
171 |
2 | -31.600 | PF00986.21; M9X0E0_MANHA/738-800; DNA gyrase B subunit, carboxyl terminus |
ali follow.. |
63 | 1 | ................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RKGLTIQRYKGLGEMNPEQLWETTMDPVARKMLQVNITDAIAADKLFSTLMGDEVEPRRDFIE........... |
63 |
3 | -30.300 | PF16898.5; K5XBZ3_PHACS/641-767; C-terminal associated domain of TOPRIM |
ali follow.. |
17 | 1 | .................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................FVTPIVRVTKGNQKINFFTIPEYEQWLENTPDHKWKSKYYKGLGTSKDEDAREYFSRMNKH-MIPFATVKDGERDLIDLAFSKKKADDRKEWLRNLEPGT..... |
100 |
4 | -13.900 | PF13589.6; A5G4D8_GEOUR/22-165; Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase |
ali follow.. |
21 | 2 | ......................................EPHSALMDIIDNSVAAD----ALNVKLYVDLVEGYRVVDDGKGM-----------DEDGIKNAFKLGSDANYKQNSL--SKYGMGLKSAGFLGLRIQIISKTEGQ........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
101 |
5 | -8.810 | PF02518.26; O52937_9CYAN/626-739; Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase |
ali follow.. |
21 | 2 | ...................................DSTRLQQVVWNLLSNAVKFTKNGGRVEIRLEVDSQAEIKVSDTGKGISPDFLPH--------VFESFR---QADATITRKFGGL-GLGLAIVRHLVE--TIYAESPGEDLGATFT.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
107 |
6 | -6.530 | PF13581.6; A9B3A3_HERA2/9-137; Histidine kinase-like ATPase domain |
ali follow.. |
16 | 24 | ...............................LNEHTAWEIELAVDEAATNIIQHAYSAERPDVRLVCGRDGVVRLFDRGVPFPETVPPPDLTSSIE-------------------TREAGGLGMYLMGRMMDDVQFNYNPETGENELHMSK................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
129 |
7 | -6.250 | PF13362.6; Q8Y0S6_RALSO/228-334; Toprim domain |
ali follow.. |
20 | 1 | ...................................................................................................................................................................................................................................................................................................................................................................................................................................................TVYIVESPNALSVECCHL----------------------------PEGTAAFALRGTANVDKIDWTFLRGKRVVIALDHTDPVN.................................................................................................................................. |
58 |
8 | -6.080 | PF11536.8; Q5JEB1_THEKO/3-242; Protein of unknown function (DUF3226 topsan) |
ali follow.. |
11 | 2 | ...................................................................................................................................................................................................................................................................................................................................................................................................................................................RLLLLEGRTDVSFFLPLIKELYG--LPVLEEGPKKKGLSRAICLSKDDTRLVVWHANGKDNLKNALKLITPAIIGIARDVDTEESILNWAKSTLQSGGFEPDVKDGYLMINGIKVIPFGIGEDARDIDLKKELELLMALLAKKESSLSKLEGISQLRKDLGRKLTPKDIMHLLAIARNYGGDSMSGLYRNFIEKLIRENRELVEEFLNESGLKE. |
234 |
9 | -5.730 | PF01751.22; RGYR_PYRHO/641-803; Toprim domain |
ali follow.. |
12 | 4 | .........................................................................................................................................................................................................................................................................................................................................................................................IVESPNKARTIASFFGQPSKRKIGDLTAYEVSIGDKMLTILASGGHMFD------------LVTNEGYHGVLILKNNGKP-YFVPVYDTIKRCRDCGHQFVDWEQKGVCPRCGSRNVHDALENVKAMR-DEILIGTDPDTEGEKIAWDIRNVLAPYAPNIKR............................................................................................................... |
157 |
10 | -5.620 | PF09929.9; Q162U3_ROSDO/97-212; Putative PD-(D/E)XK phosphodiesterase (DUF2161 topsan) |
ali follow.. |
17 | 2 | .............TVRLSDGLVEVHCDPGPYRPRKSKKRQSALLREFARRAGDPNEGGQTRAGLITAYRQDATKIFEVGASKGAEVARETGVVNATRIMRDDHYN-------EKVATGVYGLTSA............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
112 |